Drugs / Lactol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01837485 | Aug 2011 → Jan 2013 | irritable bowel syndrome | Islamic Azad University, Najafabad Branch | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01837485 ↗ |
| Known as | Symbiotic Lactol | “The Symbiotic Lactol® (Bioplus Life Sciences Pvt.) was applied 3 times a day for 3 months.” NCT01837485 ↗ |
| Modality | Other / unclassified | “the probiotic Lactol which contains Lactobacillus Sporogenes reduces the symptoms of irritable bowel syndrome.” NCT01837485 ↗ |